However, similar to our mismatch results, we observed significantly reduced protein expression of ND5 when comparing AD patients with Braak stage 5 + 6 versus controls with Braak stage 0–3 (Fig. 4B, C). Here, MT-ND5 is linked to Alzheimer disease.